Showing results (831-840 of 878) with videos related to
Sort By:
Pageof 88
British Journal of Cancer|March 6, 2015
Correlation of extended RAS and PIK3CA gene mutation status with outcomes from the phase III AGITG MAX STUDY involving capecitabine alone or in combination with bevacizumab plus or minus mitomycin C in advanced colorectal cancerT J Price, M A Bruhn, C K Lee, et al.BMC Health Services Research|May 15, 2025
Evaluating a train-the-trainer approach for implementing obstetric life support in diverse healthcare contexts throughout Arizona: a mixed methods protocolShayna D Cunningham, Rogie Royce Carandang, Laurie S Wood, et al.Annals of Oncology : Official Journal of the European Society for Medical Oncology|January 10, 2016
Quality-of-life and performance status results from the phase III RAINBOW study of ramucirumab plus paclitaxel versus placebo plus paclitaxel in patients with previously treated gastric or gastroesophageal junction adenocarcinomaS-E Al-Batran, E Van Cutsem, S C Oh, et al.Annals of Oncology : Official Journal of the European Society for Medical Oncology|June 14, 2018
Progression-free survival at 24 months (PFS24) and subsequent outcome for patients with diffuse large B-cell lymphoma (DLBCL) enrolled on randomized clinical trialsM J Maurer, T M Habermann, Q Shi, et al.ESMO Open|March 22, 2024
Phase II trial of domatinostat (4SC-202) in combination with avelumab in patients with previously treated advanced mismatch repair proficient oesophagogastric and colorectal adenocarcinoma: EMERGEE Cartwright, S Slater, C Saffery, et al.Annals of Oncology : Official Journal of the European Society for Medical Oncology|September 30, 2017
Central nervous system relapse of diffuse large B-cell lymphoma in the rituximab era: results of the UK NCRI R-CHOP-14 versus 21 trialM Gleeson, N Counsell, D Cunningham, et al.Annals of Oncology : Official Journal of the European Society for Medical Oncology|November 29, 2005
Phase III trial of 5-fluorouracil and leucovorin plus either 3H1 anti-idiotype monoclonal antibody or placebo in patients with advanced colorectal cancerG Chong, A Bhatnagar, D Cunningham, et al.Journal of Neurosurgery|April 3, 2026
The role of the blink reflex in predicting facial nerve outcomes following vestibular schwannoma surgery: a 4-year retrospective reviewJihad Abdelgadir, Tanner J Zachem, Syed M Adil, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|August 1, 1996
Randomized trial assessing the addition of interferon alpha-2a to fluorouracil and leucovorin in advanced colorectal cancer. Colorectal Cancer Working Party of the United Kingdom Medical Research CouncilM T Seymour, M L Slevin, D J Kerr, et al.Annals of Oncology : Official Journal of the European Society for Medical Oncology|July 12, 2015
Prognostic role of the LCS6 KRAS variant in locally advanced rectal cancer: results of the EXPERT-C trialF Sclafani, I Chau, D Cunningham, et al.Pageof 88